Paper29633692
Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.
Ferrari A and 3 others. Funct Neurol, 2018. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal. Papers, record 29633692. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29633692
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.
- PubMed
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Botulinum Toxins, Type A | Major topic |
| Neuromuscular Agents | Major topic |
| Humans |
Source PubMed
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19726016 | Long-term treatment of spasticity with botulinum toxin type A: an analysis of 1221 treatments in 137 patients. | Neurol Res | 2010 | https://conductscience.org/library/papers/19726016 | PubMed |
| 2 | 27268041 | In-vivo comparison of the neurotoxic potencies of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA. | Neurosci Lett | 2016 | https://conductscience.org/library/papers/27268041 | PubMed |
| 3 | 15811212 | Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. | Curr Med Res Opin | 2005 | https://conductscience.org/library/papers/15811212 | PubMed |
| 4 | 20569068 | Botulinum toxin type A in post-stroke upper limb spasticity. | Curr Med Res Opin | 2010 | https://conductscience.org/library/papers/20569068 | PubMed |
| 5 | 26866491 | The Botulinum Toxin as a Therapeutic Agent: Molecular Structure and Mechanism of Action in Motor and Sensory Systems. | Semin Neurol | 2016 | https://conductscience.org/library/papers/26866491 | PubMed |
| 6 | 7608697 | Dose standardisation of botulinum toxin. | J Neurol Neurosurg Psychiatry | 1995 | https://conductscience.org/library/papers/7608697 | PubMed |
| 7 | 17163773 | The use of small molecules to investigate molecular mechanisms and therapeutic targets for treatment of botulinum neurotoxin A intoxication. | ACS Chem Biol | 2006 | https://conductscience.org/library/papers/17163773 | PubMed |
| 8 | 27910097 | Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies. | Headache | 2017 | https://conductscience.org/library/papers/27910097 | PubMed |
| 9 | 27830925 | Headache, low back pain, other nociceptive and mixed pain conditions in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. | Eur J Phys Rehabil Med | 2016 | https://conductscience.org/library/papers/27830925 | PubMed |
| 10 | 21277940 | Modulation of botulinum toxin-induced changes in neuromuscular function with antibodies directed against recombinant polypeptides or fragments. | Neuroscience | 2011 | https://conductscience.org/library/papers/21277940 | PubMed |
| 11 | 18978494 | Potency evaluation of a formulated drug product containing 150-kd botulinum neurotoxin type A. | Clin Neuropharmacol | 2009 | https://conductscience.org/library/papers/18978494 | PubMed |
| 12 | 23185348 | Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay. | PLoS One | 2012 | https://conductscience.org/library/papers/23185348 | PubMed |
| 13 | 28356439 | Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. | Pharmacol Rev | 2017 | https://conductscience.org/library/papers/28356439 | PubMed |
| 14 | 11909903 | Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. | J Neurol Neurosurg Psychiatry | 2002 | https://conductscience.org/library/papers/11909903 | PubMed |
| 15 | 26976927 | British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin. | Pract Neurol | 2016 | https://conductscience.org/library/papers/26976927 | PubMed |
| 16 | 8613365 | Molecular composition of Clostridium botulinum type A progenitor toxins. | Infect Immun | 1996 | https://conductscience.org/library/papers/8613365 | PubMed |
| 17 | 21971766 | Measuring the potency labelling of onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin (®)) in an LD50 assay. | J Neural Transm (Vienna) | 2012 | https://conductscience.org/library/papers/21971766 | PubMed |
| 18 | 9750920 | Dose standardization of botulinum toxin. | Adv Neurol | 1998 | https://conductscience.org/library/papers/9750920 | PubMed |
| 19 | 25336912 | Botulinum toxin type A products are not interchangeable: a review of the evidence. | Biologics | 2014 | https://conductscience.org/library/papers/25336912 | PubMed |
| 20 | 24995688 | A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia. | Res Dev Disabil | 2014 | https://conductscience.org/library/papers/24995688 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42712115 | Ultrasound-guided botulinum toxin injection in patients with chronic plantar fasciitis: comparison of plantar fascia origin injection and the babcock method-a randomized controlled trial. | Future Sci OA | 2026 | https://conductscience.org/library/papers/42712115 | PubMed |
| 42033152 | Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis. | J Cosmet Dermatol | 2026 | https://conductscience.org/library/papers/42033152 | PubMed |
| 41745765 | Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41745765 | PubMed |
| 41180523 | Comparative analysis of onabotulinum toxin type-A injection techniques in older adults with blepharospasm: a retrospective cohort study. | Front Neurol | 2025 | https://conductscience.org/library/papers/41180523 | PubMed |
| 41150202 | RelabotulinumtoxinA, a Ready-to-Use Formulation Neuromodulator Manufactured with PEARL™ Technology to Maintain High Biological and Specific Activity. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/41150202 | PubMed |
| 40762356 | Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. | J Neurochem | 2025 | https://conductscience.org/library/papers/40762356 | PubMed |
| 40273416 | Exploring Nonresponse to Botulinum Toxin in Aesthetics: Narrative Review of Key Trigger Factors and Effective Management Strategies. | JMIR Dermatol | 2025 | https://conductscience.org/library/papers/40273416 | PubMed |
| 39998108 | The Role of Botulinum Toxin for Masseter Muscle Hypertrophy: A Comprehensive Review. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/39998108 | PubMed |
| 39803037 | Parkinson's Disease: Current Treatment Modalities and Emerging Therapies. | Cureus | 2024 | https://conductscience.org/library/papers/39803037 | PubMed |
| 39581944 | Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines. | Dermatol Ther (Heidelb) | 2024 | https://conductscience.org/library/papers/39581944 | PubMed |
| 39560920 | Muscle type-specific effects of bilateral abobotulinumtoxinA injection on muscle growth and contractile function in spastic mice. | FASEB J | 2024 | https://conductscience.org/library/papers/39560920 | PubMed |
| 39057946 | Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/39057946 | PubMed |
| 38922160 | Update on Non-Interchangeability of Botulinum Neurotoxin Products. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38922160 | PubMed |
| 38859620 | Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia. | Eur J Neurol | 2024 | https://conductscience.org/library/papers/38859620 | PubMed |
| 38628704 | Association analyses between the variants of SNAP25, SV2C and ST3GAL2 and the efficacy of botulinum toxin A in the treatment of the primary Meige syndrome. | Heliyon | 2024 | https://conductscience.org/library/papers/38628704 | PubMed |
| 37893140 | Botulinum Toxin Injection into the Digastric Muscle: Current Clinical Use and a Report of Five Cases. | Biomedicines | 2023 | https://conductscience.org/library/papers/37893140 | PubMed |
| 37235349 | Replacement of the Mouse LD50 Assay for Determination of the Potency of AbobotulinumtoxinA with a Cell-Based Method in Both Powder and Liquid Formulations. | Toxins (Basel) | 2023 | https://conductscience.org/library/papers/37235349 | PubMed |
| 36923693 | A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. | Clin Cosmet Investig Dermatol | 2023 | https://conductscience.org/library/papers/36923693 | PubMed |
| 36675200 | Distribution of Cleaved SNAP-25 in the Rat Brain, following Unilateral Injection of Botulinum Neurotoxin-A into the Striatum. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675200 | PubMed |
| 35965898 | Incobotulinum Toxin A with a One-year Long-lasting Effect for Trapezius Contouring and Superior Efficacy for the Treatment of Trapezius Myalgia. | J Cutan Aesthet Surg | 2022 | https://conductscience.org/library/papers/35965898 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29633692
GET https://conductscience.org/api/papers/v1/29633692/references?page=2